Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIODARONE vs VEMURAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIODARONE vs VEMURAFENIB: Safety Overview

Metric AMIODARONE VEMURAFENIB
Total FAERS Reports 25,143 8,562
Deaths Reported 3,845 1,040
Death Rate 15.3% 12.1%
Hospitalizations 13,711 2,368
Average Patient Age 69.9 yrs 58.1 yrs
% Female Patients 36.9% 45.7%
FDA Approval Date Apr 12, 2005 Aug 17, 2011
Manufacturer Aurobindo Pharma Limited Genentech, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription